Star Scientific (CIGX)
Star Scientific Revenue Growth: 649.4%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CIGX Revenue Growth Rankings
| Overall | 99th percentile | 24 of 4358 |
| Sector | 99th percentile | 1 of 386 in Consumer Goods |
| Industry | 83rd percentile | 1 of 6 in Cigarettes |
CIGX Revenue Growth Range, Past 5 Years
| Minimum | -73.39% | Jun 2008 |
| Maximum | 649.4% | Mar 2012 |
| Average | 100.4% |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these CIGX related companies
CIGX News
$CIGX http://stks.co/405f Loving CIGX here, does it pop to the highs and set new ones? I think so.
about 20 hours ago by WalkenTalken
about 20 hours ago by WalkenTalken
@missyaubaby Did you ever get back in to $CIGX ? our tech guy @walkentalken loving it still. 4 dollar calls also. Stop by our broadcast
about 3 days ago by HTB_Krull
about 3 days ago by HTB_Krull
$CIGX gross, all that accumulation at 4.00 just to let it drop. holding
about 3 days ago by Lagavulin
about 3 days ago by Lagavulin
$CIGX 130k block on 4.00 Ask got eaten away in a matter a few minutes. Bought
about 3 days ago by Lagavulin
about 3 days ago by Lagavulin
$CIGX I sold at 3.88 ad 3.98 today but I will buy over 4.00 or I will buy an EOD drop
about 3 days ago by Lagavulin
about 3 days ago by Lagavulin
@timbova $CIGX on today's watchlist. Short at open. Possible swing trade for ~3%. Will exit on RSI 30
about 3 days ago by RalfKaiser
about 3 days ago by RalfKaiser
RT $CIGX Possible catalyst, Paul Ladenson (John Hopkins, Director of endocrinology) May 25 http://stks.co/3z3s Hot Topics in Thyroidology
about 4 days ago by Lagavulin
about 4 days ago by Lagavulin
$CIGX Steady accumulation since meeting with big investors... Supreme court may deny $RAI appeal soon
about 4 days ago by Lagavulin
about 4 days ago by Lagavulin
$CIGX its gonna be great when they win their ligiations against every big tobacco company
about 5 days ago by raydoyle1
about 5 days ago by raydoyle1
$CIGX I guess the fund managers are feeling the effects of the samples from the meeting
about 11 days ago by timbova
about 11 days ago by timbova
Star Scientific Announces Patent Claims for Synthesis of Anatabine Granted by US PTO
May 16, 9:39AM Benzinga
May 16, 9:39AM Benzinga
Star Scientific Files First-Quarter Financials; Reports Continuing Increase in Anatabloc® Sales
May 10, 4:50PM PR Newswire
May 10, 4:50PM PR Newswire
Star Scientific Appoints New Vice President for Communications and Investor Relations
Apr 10, 9:40AM PR Newswire
Apr 10, 9:40AM PR Newswire
Rock Creek Pharmaceuticals and GNC Expand Anatabloc® Relationship to Nationwide Retail Store Distribution
Mar 27, 9:31AM PR Newswire
Mar 27, 9:31AM PR Newswire
PGA Tour Professional Fred Couples Named Brand Ambassador for Anatabloc™
Feb 15, 10:16AM Business Wire
Feb 15, 10:16AM Business Wire
GNC and Rock Creek Pharmaceuticals Partner to Offer Anatabloc(TM) Through GNC's Online Retail Platform
Feb 01, 10:07AM Marketwire
Feb 01, 10:07AM Marketwire
Magistrate Judge Appointed in Star Scientific Patent Infringement Lawsuit Against RJ Reynolds
Jan 26, 2:44PM Benzinga
Jan 26, 2:44PM Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CIGX | 3.98 | +0.00 | +0.00% | 579.69M |
| CIG | 17.22 | +0.06 | +0.35% | 14.69B |
| CCIX | 9.03 | +0.27 | +3.08% | 157.57M |
| CCIH | 5.44 | -0.22 | -3.89% | 131.54M |
| CCI | 54.17 | -0.14 | -0.26% | 15.41B |
| CCH | 14.30 | -1.31 | -8.39% | 5.236B |
| CCGM | 0.2126 | -0.07 | -24.10% | 4.260M |
| CCG | 10.73 | -0.03 | -0.28% | 332.84M |
| CCF | 11.72 | +0.05 | +0.43% | 105.95M |
| CNSL | 14.14 | +0.19 | +1.36% | 422.36M |
